BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37786704)

  • 1. A spatially mapped gene expression signature for intestinal stem-like cells identifies high-risk precursors of gastric cancer.
    Huang RJ; Wichmann IA; Su A; Sathe A; Shum MV; Grimes SM; Meka R; Almeda A; Bai X; Shen J; Nguyen Q; Amieva MR; Hwang JH; Ji HP
    bioRxiv; 2023 Sep; ():. PubMed ID: 37786704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology.
    Zhang G; Zheng J; Zheng L; Yu S; Jiang C; Lin W; Li D; Qu L; Wang W
    Scand J Gastroenterol; 2021 Jan; 56(1):103-110. PubMed ID: 33232631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.
    Esposito G; Pimentel-Nunes P; Angeletti S; Castro R; Libânio D; Galli G; Lahner E; Di Giulio E; Annibale B; Dinis-Ribeiro M
    Endoscopy; 2019 Jun; 51(6):515-521. PubMed ID: 30577062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
    Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
    World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more!
    Castro R; Esposito G; Libânio D; Afonso L; Annibale B; Dinis-Ribeiro M; Pimentel-Nunes P
    Scand J Gastroenterol; 2019 May; 54(5):673-677. PubMed ID: 31084230
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility of olfactomedin 4 as a molecular biomarker for early diagnosis of gastric neoplasia after intestinal metaplasia.
    Pang L; Yan X; Su D; Wu X; Jiang H
    Scand J Gastroenterol; 2023 Feb; 58(2):133-141. PubMed ID: 36124708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study.
    Nieuwenburg SAV; Mommersteeg MC; Eikenboom EL; Yu B; den Hollander WJ; Holster IL; den Hoed CM; Capelle LG; Tang TJ; Anten MP; Prytz-Berset I; Witteman EM; Ter Borg F; Burger JPW; Bruno MJ; Fuhler GM; Peppelenbosch MP; Doukas M; Kuipers EJ; Spaander MCW
    Endosc Int Open; 2021 Mar; 9(3):E297-E305. PubMed ID: 33655025
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of precancerous gastric lesions and gastric cancer through exhaled breath.
    Amal H; Leja M; Funka K; Skapars R; Sivins A; Ancans G; Liepniece-Karele I; Kikuste I; Lasina I; Haick H
    Gut; 2016 Mar; 65(3):400-7. PubMed ID: 25869737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia.
    Zhao H; Wen J; Dong X; He R; Gao C; Zhang W; Zhang Z; Shen L
    Oncotarget; 2017 Sep; 8(38):63382-63391. PubMed ID: 28968998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).
    Lee JWJ; Zhu F; Srivastava S; Tsao SK; Khor C; Ho KY; Fock KM; Lim WC; Ang TL; Chow WC; So JBY; Koh CJ; Chua SJ; Wong ASY; Rao J; Lim LG; Ling KL; Chia CK; Ooi CJ; Rajnakova A; Yap WM; Salto-Tellez M; Ho B; Soong R; Chia KS; Teo YY; Teh M; Yeoh KG
    Gut; 2022 May; 71(5):854-863. PubMed ID: 33975867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of aquaporin 3 in gastric intestinal metaplasia.
    Zhao H; Yang X; Zhou Y; Zhang W; Wang Y; Wen J; Zhang Z; Shen L
    Oncotarget; 2015 Nov; 6(36):38926-33. PubMed ID: 26506416
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wu M; Feng S; Qian M; Wang S; Zhang K
    Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
    Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface.
    Liu S; Wen H; Li F; Xue X; Sun X; Li F; Hu R; Xi H; Boccellato F; Meyer TF; Mi Y; Zheng P
    J Transl Med; 2024 May; 22(1):468. PubMed ID: 38760813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
    Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
    Pang L; Yan X; Su D
    J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study.
    Huang Y; Chen J; Guo Y; Ding Z; Liang X; Zhang W; Xue H; Zhao Y; Li X; Lu H
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37989553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.